Skip to main content
. 2022 Aug 18;13:957865. doi: 10.3389/fimmu.2022.957865

Figure 6.

Figure 6

Impact of YBX3 expression on immune/immunosuppressive cells across The Cancer Genome Atlas (TCGA) cancers and on the biomarker value of ICB sub-cohorts and YBX3 expression profile in different immune cells. (A) Correlations between YBX3 expression and infiltration of six immune cell types across all cancer types in TCGA cohorts. (B) Correlations of YBX3 expression with three immunosuppressive cell types in various TCGA cancer types. (C) Biomarker relevance of MXD3 compared to standardized cancer immune evasion biomarkers in immune checkpoint blockade sub-cohorts. (D, E) Presenting YBX3 and HEIH expression profile in different immune cells using scRNA-seq data from GEO database.